Apogee Therapeutics

acquired
acquired
Stage

About

Apogee Therapeutics develops novel antibody therapies to treat immunological and inflammatory diseases, focusing on dermatological, respiratory, and gastroenterological conditions.

Explore Apogee Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.